Generation and Characterization of SARS-CoV-2 Neutralizing Nanobodies
Single-domain antibody fragments, also called nanobodies, that target the spike glycoprotein of SARS-CoV-2 can potently neutralize the virus and prevent infection. In our first aim, we investigated whether their neutralization potency can be further increased by multimerization and generated multivalent constructs of a recently identified SARS-CoV-2 neutralizing nanobody, Ty1. We applied a novel m